Composite VC whitening and spot-fading composition, preparation method thereof and application of cosmetic

Through the whitening and lightening composition of compound VC, the synergistic effect of a variety of ascorbic acid derivatives and ergothionine is used to solve the problem of single and insignificant effects of existing whitening products, and a rapid, significant and long-lasting whitening effect is achieved.

CN120131474APending Publication Date: 2025-06-13GUANGZHOU PREXIN BIOTECHNOLOGY CO LTD
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202510481456.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2025-04-17
Publication Date
2025-06-13

AI Technical Summary

Technical Problem

The existing whitening products have problems such as single effect, insignificant effect or strong irritation. Traditional ascorbic acid derivatives have poor stability and are prone to oxidation failure, and ergothio is slow to whiten.

Method used

The whitening and lightening composition using composite VC, including magnesium ascorbic acid phosphate, sodium ascorbic acid phosphate, 3-o-ethyl ascorbic acid, ascorbic acid polypeptide, ascorbic acid glucoside and ergothionine, is used to synergize the effect of a variety of ascorbic acid derivatives to inhibit melanin formation and deposition, and form a comprehensive whitening protection system through the antioxidant effect of ergothionine.

Benefits of technology

It achieves rapid whitening and lightening effects, and the synergistic effect of multiple ascorbic acid derivatives, and the antioxidant effect of ergothione effectively prevents skin sensitivity, significantly improving the significance and durability of the whitening effect.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The invention provides a composite VC whitening and spot-fading composition, a preparation method thereof and application of cosmetics. The composition is prepared from the following components in parts by mass: 0.5 to 5 parts of magnesium ascorbyl phosphate, 0.5 to 5 parts of sodium ascorbyl phosphate, 1 to 5 parts of 3-o-ethyl ascorbic acid, 1 to 5 parts of ascorbic acid polypeptide, 0.5 to 5 parts of ascorbyl glucoside and 0.1 to 0.5 part of ergothioneine. The composition can achieve good whitening and spot-fading effects through synergistic cooperation of all the components. When the composition is applied to cosmetics, the whitening and spot-fading effects of the cosmetics can be effectively improved. Meanwhile, the preparation method of the composition is simple and easy to implement, does not need to depend on harsh conditions and complex equipment, and is easy to popularize and use.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of cosmetics, and in particular to a whitening and freckle - reducing composition containing compound VC, its preparation method and application in cosmetics. Background Art

[0002] In today's era of pursuing beauty, skin whitening and freckle reduction are one of the core demands of many consumers. Skin problems such as freckles and dullness not only affect the appearance but also may have a negative impact on personal confidence. There are a wide variety of existing whitening products, but most of them have problems such as single efficacy, insignificant effect or strong irritation.

[0003] Although traditional ascorbic acid and some of its derivatives have certain whitening ability and can inhibit the activity of tyrosinase to hinder melanin production, they often have disadvantages such as poor stability, easy oxidation and inactivation when used alone, and are prone to cause skin sensitivity when used at high concentrations. As a new emerging natural antioxidant, ergothioneine shows potential in combating free radicals and preventing pigmentation. However, its whitening effect is slow when used alone, making it difficult to meet consumers' expectations for quickly improving skin color. Summary of the Invention

[0004] Based on the above problems, the present invention provides a whitening and freckle - reducing composition containing compound VC, its preparation method and application in cosmetics. The composition can achieve a rapid whitening and freckle - reducing effect.

[0005] To achieve the above object, the present invention adopts the following technical solutions:

[0006] A whitening and freckle - reducing composition containing compound VC, comprising the following components in parts by mass: magnesium ascorbyl phosphate 0.5 - 5 parts, sodium ascorbyl phosphate 0.5 - 5 parts, 3 - O - ethyl ascorbic acid 1 - 5 parts, ascorbic acid polypeptide 1 - 5 parts, ascorbyl glucoside 0.5 - 5 parts, and ergothioneine 0.1 - 0.5 parts.

[0007] Optionally, the whitening and freckle - reducing composition containing compound VC comprises the following components in parts by mass: magnesium ascorbyl phosphate 1 - 3 parts, sodium ascorbyl phosphate 1 - 3 parts, 3 - O - ethyl ascorbic acid 2 - 4 parts, ascorbic acid polypeptide 2 - 4 parts, ascorbyl glucoside 1 - 3 parts, and ergothioneine 0.2 - 0.4 parts.

[0008] Optionally, calculated as the mass percentage of the total mass of magnesium ascorbyl phosphate, sodium ascorbyl phosphate, 3 - O - ethyl ascorbic acid, ascorbic acid polypeptide, and ascorbyl glucoside, the mass percentage of ergothioneine is 1% - 3%.

[0009] Optionally, the mass ratio of magnesium ascorbyl phosphate, sodium ascorbyl phosphate, 3 - O - ethyl ascorbic acid, ascorbic acid polypeptide, ascorbyl glucoside, and ergothioneine is 1:1:1.2:1:1:0.1.

[0010] A method for preparing a whitening and freckle - reducing composition of the above - mentioned composite VC, comprising the following steps:

[0011] Mix magnesium ascorbyl phosphate, sodium ascorbyl phosphate, 3 - O - ethyl ascorbic acid, ascorbic acid polypeptide, ascorbyl glucoside, and ergothioneine with a solvent, stir to dissolve, and then remove the solvent to obtain the whitening and freckle - reducing composition of the composite VC.

[0012] Optionally, the solvent includes at least one of water and polyols; the polyols include at least one of propylene glycol and butylene glycol.

[0013] Optionally, the stirring and dissolving is carried out at 35°C - 45°C; the time for stirring and dissolving is 20 min - 50 min; the stirring speed for stirring and dissolving is 500 rpm - 800 rpm.

[0014] The application of the whitening and freckle - reducing composition of the above - mentioned composite VC in cosmetics, preparing the whitening and freckle - reducing composition of the composite VC into essence, emulsion, mask, cream or eye cream.

[0015] A cosmetic, comprising the whitening and freckle - reducing composition of the above - mentioned composite VC.

[0016] Optionally, the mass percentage of the whitening and freckle - reducing composition of the composite VC in the cosmetic is 0.5% - 10%.

[0017] Beneficial effects

[0018] In the composition of the present invention, multiple ascorbic acid derivatives (VC) synergistically enhance the effect, inhibiting the formation and deposition of melanin from different pathways. Magnesium ascorbyl phosphate and sodium ascorbyl phosphate have good stability, can continuously provide reducing power for the skin, and effectively hinder the process of tyrosinase - catalyzed melanin synthesis. 3 - O - ethyl ascorbic acid, due to its high lipophilicity, is more likely to penetrate the skin cutin layer and act deeply on melanocytes to enhance the whitening effect. Ascorbic acid polypeptide not only has the function of inhibiting tyrosinase activity but also can promote the decomposition and excretion of melanin by regulating cell metabolism. Ascorbyl glucoside can slowly release active vitamin C in the skin, extending the whitening time effect. Ergothioneine, as a powerful antioxidant, scavenges excessive free radicals in the skin, prevents free - radical - induced tyrosinase activation and melanin production, and cooperates with ascorbic acid derivatives to form an all - round whitening protection system, thereby obtaining a rapid whitening and freckle - reducing effect. Detailed implementation mode

[0019] An embodiment of the present invention provides a whitening and freckle - reducing composition containing compound VC, which comprises the following components in parts by mass: magnesium ascorbyl phosphate 0.5 - 5 parts, sodium ascorbyl phosphate 0.5 - 5 parts, 3 - O - ethyl ascorbic acid 1 - 5 parts, ascorbyl polypeptide 1 - 5 parts, ascorbyl glucoside 0.5 - 5 parts, and ergothioneine 0.1 - 0.5 parts. In this embodiment, through the synergistic cooperation of various ascorbic acid derivatives and ergothioneine, an all - round whitening protection system can be formed, thereby obtaining a rapid whitening and freckle - reducing effect.

[0020] Optionally, in the whitening and freckle - reducing composition containing compound VC, the mass fraction of magnesium ascorbyl phosphate can be 0.5 part, 1 part, 1.5 parts, 2 parts, 2.5 parts, 3 parts, 3.5 parts, 4 parts, 4.5 parts, 5 parts, etc. It can be understood that the mass fraction of magnesium ascorbyl phosphate can also make other appropriate selections within the range of 0.5 - 5 parts.

[0021] Optionally, in the whitening and freckle - reducing composition containing compound VC, the mass fraction of sodium ascorbyl phosphate can be 0.5 part, 1 part, 1.5 parts, 2 parts, 2.5 parts, 3 parts, 3.5 parts, 4 parts, 4.5 parts, 5 parts, etc. It can be understood that the mass fraction of sodium ascorbyl phosphate can also make other appropriate selections within the range of 0.5 - 5 parts.

[0022] Optionally, in the whitening and freckle - reducing composition containing compound VC, the mass fraction of 3 - O - ethyl ascorbic acid can be 1 part, 1.5 parts, 2 parts, 2.5 parts, 3 parts, 3.5 parts, 4 parts, 4.5 parts, 5 parts, etc. It can be understood that the mass fraction of 3 - O - ethyl ascorbic acid can also make other appropriate selections within the range of 1 - 5 parts.

[0023] Optionally, in the whitening and freckle - reducing composition containing compound VC, the mass fraction of ascorbyl polypeptide can be 1 part, 1.5 parts, 2 parts, 2.5 parts, 3 parts, 3.5 parts, 4 parts, 4.5 parts, 5 parts, etc. It can be understood that the mass fraction of ascorbyl polypeptide can also make other appropriate selections within the range of 1 - 5 parts.

[0024] Optionally, in the whitening and freckle - reducing composition containing compound VC, the mass fraction of ascorbyl glucoside can be 0.5 part, 1 part, 1.5 parts, 2 parts, 2.5 parts, 3 parts, 3.5 parts, 4 parts, 4.5 parts, 5 parts, etc. It can be understood that the mass fraction of ascorbyl glucoside can also make other appropriate selections within the range of 0.5 - 5 parts.

[0025] Optionally, in the whitening and freckle-reducing composition of compound VC, the mass fraction of ergothioneine can be 0.1 part, 0.2 parts, 0.3 parts, 0.4 parts, 0.5 parts, etc. It can be understood that the mass fraction of ergothioneine can also be other suitable choices within the range of 0.1 - 0.5 parts.

[0026] In some embodiments, the whitening and freckle-reducing composition of compound VC is composed of the following components in parts by mass: magnesium ascorbyl phosphate 0.5 - 5 parts, sodium ascorbyl phosphate 0.5 - 5 parts, 3 - O - ethyl ascorbic acid 1 - 5 parts, ascorbic acid polypeptide 1 - 5 parts, ascorbyl glucoside 0.5 - 5 parts, and ergothioneine 0.1 - 0.5 parts.

[0027] Optionally, the whitening and freckle-reducing composition of compound VC includes the following components in parts by mass: magnesium ascorbyl phosphate 1 - 3 parts, sodium ascorbyl phosphate 1 - 3 parts, 3 - O - ethyl ascorbic acid 2 - 4 parts, ascorbic acid polypeptide 2 - 4 parts, ascorbyl glucoside 1 - 3 parts, and ergothioneine 0.2 - 0.4 parts. At this time, it is more conducive to promoting the rapid whitening effect of the composition.

[0028] Optionally, calculated as the mass percentage of the total mass of magnesium ascorbyl phosphate, sodium ascorbyl phosphate, 3 - O - ethyl ascorbic acid, ascorbic acid polypeptide, and ascorbyl glucoside, the mass percentage of ergothioneine is 1% - 3%. At this time, the synergy of various ascorbic acid derivatives and ergothioneine can effectively solve the problem of the slow onset of ergothioneine, promote the rapid antioxidant effect of ergothioneine, and continuously exert the antioxidant effect. On the basis of enabling the composition to exert a rapid whitening effect, it continuously exerts the whitening effect.

[0029] Furthermore, calculated as the mass percentage of the total mass of magnesium ascorbyl phosphate, sodium ascorbyl phosphate, 3 - O - ethyl ascorbic acid, ascorbic acid polypeptide, and ascorbyl glucoside, the mass percentage of ergothioneine can be 1%, 1.5%, 2%, 2.5%, 3%, etc. It can be understood that the mass percentage of ergothioneine can also be other suitable choices within the range of 1% - 3%.

[0030] In one embodiment, the mass ratio of magnesium ascorbyl phosphate, sodium ascorbyl phosphate, 3 - O - ethyl ascorbic acid, ascorbic acid polypeptide, ascorbyl glucoside, and ergothioneine is 1:1:1.2:1:1:0.1.

[0031] Another embodiment of the present invention provides a method for preparing the above-mentioned whitening and freckle-reducing composition of composite VC, which includes the following steps: Mix magnesium ascorbyl phosphate, sodium ascorbyl phosphate, 3-O-ethyl ascorbic acid, ascorbic acid polypeptide, ascorbyl glucoside and ergothioneine with a solvent, stir to dissolve, and then remove the solvent to obtain the whitening and freckle-reducing composition of composite VC. The preparation method of this embodiment is simple and convenient, without special equipment and strict process conditions, and can be easily realized in a conventional laboratory or a cosmetics production workshop, which is conducive to large-scale popularization and application.

[0032] Optionally, the solvent includes at least one of water and polyols. The polyols include at least one of propylene glycol and butylene glycol.

[0033] In one embodiment, the stirring and dissolving is carried out at 35°C - 45°C. The time for stirring and dissolving is 20 min - 50 min. The stirring speed for stirring and dissolving is 500 rpm - 800 rpm.

[0034] Optionally, the temperature for stirring and dissolving can be 35°C, 36°C, 37°C, 38°C, 39°C, 40°C, 41°C, 42°C, 43°C, 44°C, 45°C, etc. It can be understood that the temperature for stirring and dissolving can also make other suitable selections within the range of 35°C - 45°C.

[0035] Optionally, the time for stirring and dissolving can be 20 min, 25 min, 30 min, 35 min, 40 min, 45 min, 50 min, etc. It can be understood that the time for stirring and dissolving can also make other suitable selections within the range of 20 min - 50 min.

[0036] Optionally, the stirring speed for stirring and dissolving can be 500 rpm, 550 rpm, 600 rpm, 650 rpm, 700 rpm, 750 rpm, 800 rpm, etc. It can be understood that the stirring speed for stirring and dissolving can also make other suitable selections within the range of 500 rpm - 800 rpm.

[0037] Optionally, the method for removing the solvent includes vacuum distillation, rotary evaporation, freeze-drying, etc.

[0038] Another embodiment of the present invention provides an application of the above-mentioned whitening and freckle-reducing composition of composite VC in cosmetics. This application includes: making the whitening and freckle-reducing composition of composite VC into essence, essence milk, mask, cream or eye cream.

[0039] Another embodiment of the present invention provides a cosmetic, which includes the above-mentioned whitening and freckle-reducing composition of composite VC.

[0040] Furthermore, the mass percentage of the whitening and freckle-reducing composition of compound VC in the cosmetic is 0.5%-10%. In the cosmetic, the whitening and freckle-reducing composition of compound VC can be flexibly adjusted within the range of 0.5%-10%, which can not only ensure the full play of the whitening and freckle-reducing effect, but also take into account the overall stability and usability of the product. By using the cosmetic containing this composition, consumers can observe the effects of skin tone brightening and freckle fading in a relatively short time, and long-term use can make the skin return to a fair, smooth and healthy state.

[0041] Optionally, the cosmetic includes essence, emulsion, mask, cream or eye cream.

[0042] Example 1

[0043] In this example, the preparation method of the whitening and freckle-reducing composition of compound VC is as follows:

[0044] Mix 1 part of magnesium ascorbyl phosphate, 1 part of sodium ascorbyl phosphate, 1.2 parts of 3-O-ethylascorbic acid, 1 part of ascorbyl polypeptide, 1 part of ascorbyl glucoside and 0.1 part of ergothioneine with deionized water, stir at a stirring speed of 600 rpm at 40°C for 30 min, and then remove the deionized water by vacuum distillation to obtain the whitening and freckle-reducing composition of compound VC.

[0045] Example 2

[0046] Compared with Example 1, the difference in Example 2 is: 0.5 part of magnesium ascorbyl phosphate, 0.5 part of sodium ascorbyl phosphate, 1 part of 3-O-ethylascorbic acid, 1 part of ascorbyl polypeptide, 0.5 part of ascorbyl glucoside and 0.1 part of ergothioneine.

[0047] Example 3

[0048] Compared with Example 1, the difference in Example 3 is: 3 parts of magnesium ascorbyl phosphate, 3 parts of sodium ascorbyl phosphate, 4 parts of 3-O-ethylascorbic acid, 4 parts of ascorbyl polypeptide, 3 parts of ascorbyl glucoside and 0.4 part of ergothioneine.

[0049] Example 4

[0050] Compared with Example 1, the difference in Example 4 is: 5 parts of magnesium ascorbyl phosphate, 5 parts of sodium ascorbyl phosphate, 5 parts of 3-O-ethylascorbic acid, 5 parts of ascorbyl polypeptide, 5 parts of ascorbyl glucoside and 0.5 part of ergothioneine.

[0051] Comparative Example 1

[0052] Compared with Example 1, the difference in Comparative Example 1 is: replacing magnesium ascorbyl phosphate with an equal mass of ergothioneine.

[0053] Comparative Example 2

[0054] Compared with Example 1, the difference in Comparative Example 2 is that ergothioneine is replaced with magnesium ascorbyl phosphate of equal mass.

[0055] Comparative Example 3

[0056] Compared with Example 1, the difference in Comparative Example 3 is that 3 - O - ethyl ascorbic acid is replaced with magnesium ascorbyl phosphate of equal mass.

[0057] Comparative Example 4

[0058] Compared with Example 1, the difference in Comparative Example 4 is that ascorbic acid polypeptide is replaced with magnesium ascorbyl phosphate of equal mass.

[0059] Comparative Example 5

[0060] Compared with Example 1, the difference in Comparative Example 5 is that ascorbyl glucoside is replaced with magnesium ascorbyl phosphate of equal mass.

[0061] Test Example

[0062] Test subjects: 90 volunteers aged 25 - 45 years old with pigmentation problems such as moderate melasma or freckles on the face, randomly divided into 9 groups, 10 people in each group, 5 men and 5 women.

[0063] The compositions of the Examples and Comparative Examples were formulated into creams. Among them, the mass percentage of the composition in the cream was 2%.

[0064] The creams of the Examples and Comparative Examples were used on the 9 groups of volunteers respectively.

[0065] Before the start of the test, the test area on the face of all volunteers (selecting the cheek area where the spots are more concentrated, with an area of about 4 cm 2 ) was measured for the initial skin chromaticity. After 4 weeks of use, the chromaticity at the same position was measured again, and the increase in L value (brightness value, the higher the value, the brighter and whiter the skin), the increase in a value (red - green value, positive value indicates a tendency towards red, negative value indicates a tendency towards green), and the increase in b value (yellow - blue value, positive value indicates a tendency towards yellow, negative value indicates a tendency towards blue) were calculated. The usage frequency was 3 times a week. The average value of each group was taken as the test value. The test results are shown in Table 1. During the test, the incidence of sensitivity was observed, and the incidence of sensitivity = the number of volunteers with skin sensitivity / 10 × 100%.

[0066] L value increase a value increase b value increase Sensitivity incidence rate Example 1 6.2 0.6 0.8 0 Example 2 5.1 0.4 0.5 0 Example 3 5.8 0.5 0.6 0 Example 4 5.2 0.4 0.4 0 Comparative example 1 0.8 0.1 0.1 40% Comparative example 2 2.3 0.2 0.1 30% Comparative example 3 2.7 0.2 0.2 30% Comparative example 4 1.9 0.1 0.2 20% Comparative example 5 2.1 0.2 0.1 20%

[0067] As can be seen from Table 1, the composition in the Example has a better whitening effect compared with the Comparative Examples, and can effectively reduce the incidence of skin sensitivity.

[0068] The above are only the preferred embodiments of the present invention and are not intended to limit the present invention. Any modifications, equivalent replacements, improvements, etc. made within the spirit and principles of the present invention shall be included within the protection scope of the present invention.

[0069] For those of ordinary skill in the art, according to the idea of the present invention, there will be changes in the specific implementation manners and application scopes. In summary, the content of this specification should not be construed as a limitation to the present invention.

Claims

1. A whitening and spot-lightening composition containing VC, characterized in that: The invention comprises the following components in parts by weight: 0.5-5 parts of magnesium ascorbyl phosphate, 0.5-5 parts of sodium ascorbyl phosphate, 1-5 parts of 3-o-ethyl ascorbic acid, 1-5 parts of ascorbic acid polypeptide, 0.5-5 parts of ascorbyl glucoside and 0.1-0.5 parts of ergothioneine.

2. The VC-containing whitening and spot-lightening composition according to claim 1, characterized in that: The invention comprises the following components in parts by weight: 1-3 parts of magnesium ascorbyl phosphate, 1-3 parts of sodium ascorbyl phosphate, 2-4 parts of 3-o-ethyl ascorbic acid, 2-4 parts of ascorbic acid polypeptide, 1-3 parts of ascorbyl glucoside and 0.2-0.4 parts of ergothioneine.

3. The VC-containing whitening and spot-lightening composition according to claim 1, characterized in that: The mass percentage of the ergothioneine is 1%-3% based on the mass percentage of the total mass of the magnesium ascorbyl phosphate, the sodium ascorbyl phosphate, the 3-o-ethyl ascorbic acid, the ascorbic acid polypeptide and the ascorbyl glucoside.

4. The VC-containing whitening and spot-lightening composition according to any one of claims 1 to 3, characterized in that: The mass ratio of the magnesium ascorbyl phosphate, the sodium ascorbyl phosphate, the 3-o-ethyl ascorbic acid, the ascorbic acid polypeptide, the ascorbic acid glucoside and the ergothioneine is 1:1:1.2:1:1:0.

1.

5. A method for preparing the VC-containing whitening and spot-lightening composition according to any one of claims 1 to 4, characterized in that: The steps include: The magnesium ascorbyl phosphate, the sodium ascorbyl phosphate, the 3-o-ethyl ascorbic acid, the ascorbic acid polypeptide, the ascorbic acid glucoside and the ergothioneine are mixed with a solvent, stirred to dissolve, and then the solvent is removed to obtain the composite VC whitening and spot-lightening composition.

6. The method for preparing the VC-compounded whitening and spot-lightening composition according to claim 5, characterized in that: The solvent includes at least one of water and a polyol; the polyol includes at least one of propylene glycol and butylene glycol.

7. The method for preparing the VC-containing whitening and spot-lightening composition according to any one of claims 5 to 6, characterized in that: The stirring and dissolving is carried out at 35° C.-45° C.; the time of the stirring and dissolving is 20 min-50 min; and the stirring speed of the stirring and dissolving is 500 rpm-800 rpm.

8. Use of the VC-containing whitening and spot-lightening composition according to any one of claims 1 to 4 in cosmetics, characterized in that: The VC-compounded whitening and spot-lightening composition is prepared into essence, essence milk, facial mask, facial cream or eye cream.

9. A cosmetic, characterized in that: A whitening and spot-lightening composition comprising the composite VC according to any one of claims 1 to 4.

10. The cosmetic according to claim 9, characterized in that The mass percentage of the whitening and spot-lightening composition containing VC is 0.5%-10% of the cosmetic.

Citation Information

Cited By

  • Vitamin C derivative composition as well as preparation and application thereof

    CN122097189A